Literature DB >> 20195941

[Early deep brain stimulation for Parkinson's disease].

A Schnitzler1, G Fuchs, H Baas, U Dillmann, R Hilker, M Oechsner.   

Abstract

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a powerful treatment for advanced Parkinson's disease with levodopa-induced motor complications. Randomized controlled studies have shown that motor fluctuations and quality of life are significantly more improved by STN-DBS than by best medical treatment. The main delay before neurosurgery is currently 14 years after diagnosis. Clinical pilot data suggest that neurosurgery performed already with beginning motor fluctuations and an average disease duration of 7 years may lead to earlier improvement of motor deficits and quality of life, thus preventing disease-related psycho-social decline, and extending the period of beneficial effects of STN-DBS. Results of an ongoing multicenter trial (EARLYSTIM) comparing the effects of STN-DBS and best medical treatment on motor symptoms, quality of life, and psycho-social adaptation will be available in 2 years time and will clarify whether or not early STN-DBS is superior to best medical treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20195941     DOI: 10.1055/s-0029-1245159

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  2 in total

1.  [Deep brain stimulation - expectations and doubts. A nationwide questionnaire study of patients with Parkinson's disease and their family members].

Authors:  M Südmeyer; J Volkmann; L Wojtecki; G Deuschl; A Schnitzler; B Möller
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

Review 2.  [Nuclear medicine imaging in patients with Parkinson's syndrome: an update].

Authors:  J Schwarz
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.